Zyloprim: Effective Uric Acid Control for Gout Management
Zyloprim
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.35 | $63.00 (0%) | 🛒 Add to cart |
| 270 | $0.32 | $94.50 $87.00 (8%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $126.00 $110.00 (13%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.00 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $64.50 $53.00 (18%) | 🛒 Add to cart |
| 120 | $0.53 | $86.00 $64.00 (26%) | 🛒 Add to cart |
| 180 | $0.47 | $129.00 $84.00 (35%) | 🛒 Add to cart |
| 270 | $0.42 | $193.50 $114.00 (41%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $258.00 $144.00 (44%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Zyloprim, with the active ingredient allopurinol, is a cornerstone pharmaceutical therapy in the long-term management of gout and conditions marked by elevated uric acid levels (hyperuricemia). It functions as a xanthine oxidase inhibitor, targeting the underlying metabolic cause of urate crystal formation rather than merely addressing acute inflammatory symptoms. This expert guide provides a comprehensive overview of Zyloprim, detailing its mechanism, appropriate use, and essential safety information for healthcare professionals and informed patients. Proper management with this medication can significantly reduce the frequency of painful gout attacks and prevent long-term joint damage.
Features
- Active Ingredient: Allopurinol.
- Drug Class: Xanthine oxidase inhibitor.
- Available Formulations: Oral tablets (100 mg and 300 mg).
- Mechanism of Action: Inhibits the enzyme xanthine oxidase, which is responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid.
- Prescription Status: Requires a prescription from a licensed healthcare provider.
Benefits
- Prevents Gout Attacks: Reduces the frequency and severity of acute gout flares by maintaining lower serum uric acid levels, preventing the formation of monosodium urate crystals.
- Prevents Tissue Damage: Long-term use helps prevent the development of debilitating complications such as chronic tophaceous gout, joint erosion, and renal damage associated with urate nephropathy.
- Manages Secondary Hyperuricemia: Effectively controls elevated uric acid levels caused by certain cancers and their therapies (tumor lysis syndrome) or by diuretic use.
- Reduces Kidney Stone Risk: Lowers the urinary excretion of uric acid, thereby decreasing the likelihood of forming uric acid kidney stones.
- Chronic Disease Management: Provides a proactive, preventive strategy for a chronic metabolic condition, moving beyond reactive pain management.
Common use
Zyloprim (allopurinol) is primarily indicated for the management of:
- Chronic Gout: For patients with recurrent gout attacks, tophi, or radiographic evidence of joint damage.
- Hyperuricemia: Secondary to polycythemia vera, myeloid metaplasia, other malignancies, and during cancer chemotherapy which causes rapid cell turnover.
- Recurrent Uric Acid Nephrolithiasis: For patients with a history of recurrent formation of uric acid kidney stones. It is crucial to note that Zyloprim is not a treatment for an acute gout attack. In fact, initiating therapy during an acute flare may prolong the attack. Anti-inflammatory prophylaxis (e.g., with NSAIDs or colchicine) is often recommended during the initial months of allopurinol therapy to prevent such flares, which can occur due to the mobilization of urate from tissue deposits as serum levels fall.
Dosage and direction
Dosage must be individualized and titrated based on serum uric acid levels. The goal is to achieve and maintain a serum uric acid level below 6 mg/dL.
- Adults (Gout & Hyperuricemia): The recommended starting dose is 100 mg once daily. The dose may be increased by 100 mg weekly until a serum uric acid level of ≤6 mg/dL is achieved. The typical maintenance dose is 200-300 mg daily for mild gout, and 400-600 mg daily for moderate to severe tophaceous gout. Doses exceeding 300 mg per day should be administered in divided doses.
- Children (Secondary Hyperuricemia from Malignancy): Dose is based on body surface area or weight, typically 10-20 mg/kg/day up to a maximum of 400 mg daily, administered in divided doses.
- Renal Impairment: Dosage adjustment is mandatory. A lower initial dose and slower titration are required. Specific dosing guidelines based on creatinine clearance (e.g., 100 mg/day for CrCl 10-20 mL/min, 100 mg every other day for CrCl 3-10 mL/min) must be strictly followed.
- Administration: Tablets should be taken orally with a full glass of water. To minimize the potential for kidney stone formation and to aid in excretion, adequate daily fluid intake (enough to yield at least 2 liters of urine per day) is essential. It can be taken with or without food, but taking it after meals may minimize potential stomach upset.
Precautions
- Hypersensitivity Syndrome: Allopurinol has been associated with a rare but severe and sometimes fatal hypersensitivity reaction, known as allopurinol hypersensitivity syndrome (AHS). This can include severe skin reactions (e.g., Stevens-Johnson Syndrome, toxic epidermal necrolysis), fever, lymphadenopathy, eosinophilia, and hepatitis. Discontinue Zyloprim immediately at the first appearance of skin rash or any sign of hypersensitivity.
- Renal Impairment: Patients with impaired renal function are at increased risk of severe hypersensitivity reactions and other adverse effects. Use with extreme caution and adhere to renal dosing guidelines.
- Hepatic Impairment: Periodic liver function tests are recommended during therapy. Discontinue if liver function abnormalities occur.
- Bone Marrow Suppression: Asymptomatic leukopenia or thrombocytopenia has been reported. Periodic complete blood counts are advisable.
- Asymptomatic Hyperuricemia: Zyloprim is generally not recommended for treating asymptomatic hyperuricemia.
Contraindications
Zyloprim is contraindicated in patients with:
- A history of a severe hypersensitivity reaction to allopurinol or any component of the formulation.
- Patients who are currently experiencing an acute gout attack.
- Concomitant use with didanosine (contraindication due to increased risk of didanosine toxicity).
Possible side effect
Common side effects may include:
- Skin rash (maculopapular) - most common
- Nausea, vomiting, diarrhea
- Drowsiness, headache
- Changes in liver function tests
Serious side effects requiring immediate medical attention include:
- Signs of hypersensitivity syndrome (severe skin rash, blistering, peeling, itching, fever, swollen glands, flu-like symptoms, unusual tiredness)
- Signs of liver problems (persistent nausea/vomiting, loss of appetite, dark urine, yellowing of eyes/skin, right upper abdominal pain)
- Signs of kidney problems (change in amount of urine, blood in urine)
- Easy bruising/bleeding, signs of infection (fever, chills, persistent sore throat)
- Eye pain, vision changes
- Numbness/tingling of arms/legs
Drug interaction
Zyloprim interacts with several medications, including:
- Azathioprine & 6-Mercaptopurine: Allopurinol inhibits their metabolism, dramatically increasing their toxicity. The dose of these drugs must be reduced to 1/4 to 1/3 of the usual dose when co-administered.
- Didanosine: Contraindicated. Allopurinol increases plasma concentrations of didanosine.
- Warfarin: Allopurinol may potentiate the anticoagulant effect, increasing the risk of bleeding. INR should be monitored closely.
- Diuretics (especially Thiazides): May increase the risk of hypersensitivity reactions to allopurinol.
- Ampicillin/Amoxicillin: Increased incidence of skin rash when used concomitantly.
- Cyclophosphamide: May enhance the bone marrow suppression effects of cyclophosphamide.
- Theophylline: Allopurinol may increase serum theophylline levels.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to catch up. Maintaining a consistent daily schedule is important for effective uric acid control.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, and dizziness. In massive overdoses, acute renal failure may occur. There is no specific antidote. Treatment is supportive and includes vigorous hydration to promote excretion and management of symptoms. Hemodialysis may be effective in removing allopurinol and its primary active metabolite, oxypurinol, from the bloodstream.
Storage
Store Zyloprim tablets at room temperature (20°-25°C or 68°-77°F) in a tightly closed container. Keep away from light, excess heat, and moisture (i.e., not in a bathroom). Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- “As a rheumatologist with over 20 years of experience, allopurinol remains a first-line, foundational therapy for my patients with chronic gout. When dosed correctly and with appropriate patient education, it is highly effective and well-tolerated for long-term urate-lowering therapy.” – Dr. A. Reynolds, MD
- “After suffering from debilitating gout attacks for years, starting Zyloprim changed my life. The first few months required patience and prophylactic medication, but I haven’t had a major flare in over two years. It requires discipline but is worth it.” – John D., Patient
- “The potential for severe hypersensitivity reactions, while rare, mandates careful patient selection and vigilant monitoring, especially in the initial phase of treatment. The benefits for appropriate patients, however, are unequivocal.” – Clinical Pharmacist Review
- “Managing my father’s medication after his cancer diagnosis included Zyloprim to prevent tumor lysis syndrome. It was a critical part of his care plan and helped him avoid serious metabolic complications during chemotherapy.” – Caregiver testimonial